Morphology Gender All-age DALYs, no. 3 (95% UI) Age-standardized DALY Rate (95% UI), per 100,000 1990 2019 Change, % 1990 2019 Change, % All neoplasms Male 26665.90 (20491.53, 32634.11) 42241.06 (32906.13, 52726.38) 58.41 5642.34 (4386.93,6859.92) 4375.35 (3430.65,5424.80) -22.46 Female 16502.20 (12752.07, 20516.94) 23028.20 (17744.80,28622.55) 39.55 3456.54 (2687.74,4276.93) 2301.10 (1773.10,2853.61) -33.43 Both 43168.10 (35243.76,51219.97) 65269.26 (53487.48,77903.09) 51.20 4516.45 (3703.94,5337.17) 3288.22 (2704.53,3910.50) -27.19 Tracheal, bronchus, and lung cancer Male 4864.23 (3954.89,5914.77) 11967.77 (9374.37,14952.33) 146.04 1084.53 (891.58,1310.23) 1203.78 (950.19,1495.1) 11.00 Female 2096.64 (1730.33,2468.93) 5160.82 (4138.83,6353.14) 146.15 456.89 (377.41,535.53) 492.17 (393.74,604.27) 7.72 Both 6960.87 (5966.96,8039.13) 17128.58 (14340.49,20231.34) 146.07 760.68 (654.28,875.37) 831.27 (699.11,979.99) 9.28 Stomach cancer Male 5409.61 (4428.71,6387.35) 7135.99 (5633.55,8786.15) 31.91 1205.79 (992.78,1421.38) 718.79 (571.96,877.30) -40.39 Female 2839.18 (2341.70,3338.41) 2689.00 (2162.24,3333.93) -5.29 619.82 (513.84,726.15) 260.97 (209.75,323.21) -57.90 Both 8248.79 (7173.64,9366.34) 9824.99 (8191.72,11632.86) 19.11 905.54 (791.75,1024.49) 481.15 (403.20,567.36) -46.87 Colorectal cancer Male 1237.93 (1024.37,1469.8) 4168.63 (3354.03,5154.83) 236.74 272.77 (228.96,321.10) 434.5 (353.42,531.60) 59.29 Female 1033.38 (860.91,1210.10) 2226.29 (1811.95,2708.17) 115.44 223.02 (186.75,260.80) 217.28 (176.73,264.24) -2.57 Both 2271.31 (1988.09,2566.70) 6394.92 (5462.29,7408.70) 181.55 245.60 (215.43,276.40) 320.57 (275.4,370.70) 30.53 Esophageal cancer Male 3127.52 (1947.69,3810.76) 4622.3 (3552.36,5810.37) 47.79 707.12 (443.86,855.35) 458.55 (354.39,572.18) -35.15 Female 1366.55 (742.99,1637.54) 1137.70 (809.67,1428.72) -16.75 311.63 (172.06,371.98) 108.46 (76.74,135.97) -65.20 Both 4494.07 (2848.08,5295.22) 5760.00 (4581.77,6999.57) 28.17 506.98 (321.63,593.47) 277.50 (221.69,335.87) -45.26 Liver cancer Male 5590.40 (4500.90,6841.76) 4145.80 (3241.13,5167.31) -25.84 1102.84 (889.18,1343.26) 414.90 (326.97,514.24) -62.38 Female 1987.37 (1593.34,2470.03) 1179.67 (936.01,1453.06) -40.64 420.06 (338.28,520.01) 115.85 (92.14,142.16) -72.42 Both 7577.77 (6419.83,8981.02) 5325.46 (4425.69,6374.59) -29.72 769.11 (653.21,913.07) 264.31 (220.69,315.14) -65.63 Leukemia Male 2130.99 (1362.49,2578.72) 1365.39 (1030.96,1668.32) -35.93 352.83 (229.15,429.38) 190.81 (144.9,235.81) -45.92 Female 1762.75 (1317.40,2177.36) 943.92 (729.07,1151.66) -46.45 315.55 (238.95,387.64) 135.97 (106.51,162.94) -56.91 Both 3893.74 (3068.11,4551.14) 2309.31 (1924.58,2691.12) -40.69 333.77 (263.69,390.45) 163.82 (136.6,189.48) -50.92 Cervical cancer Female 855.36 (654.48,1432.99) 1622.24 (892.58,2090.86) 89.66 176.4 (135.68,294.69) 157.50 (86.90,202.91) -10.71 Breast cancer Male 11.62 (9.46,14.00) 80.21 (61.44,100.88) 590.28 2.45 (2.00,2.93) 7.73 (5.98,9.62) 215.51 Female 1423.49 (1173.66,1696.00) 2877.24 (2323.69,3513.54) 102.13 294.04 (243.51,349.12) 277.98 (224.35,339.93) -5.46 Both 1435.10 (1184.14,1708.68) 2957.45 (2408.51,3590.17) 106.08 145.67 (121.08,172.57) 144.15 (117.26,174.99) -1.04 Pancreatic cancer Male 455.55 (367.84,555.91) 1760.52 (1381.02,2203.79) 286.46 99.25 (81.00,120.14) 176.41 (139.31,219.18) 77.74 Female 293.87 (243.00,345.65) 1044.66 (837.73,1279.10) 255.48 64.48 (53.69,75.61) 98.93 (79.22,121.02) 53.43 Both 749.41 (644.18,863.72) 2805.18 (2368.77,3276.55) 274.32 81.48 (70.48,93.24) 136.57 (115.59,158.93) 67.61 Brain and central nervous system cancer Male 1005.83 (655.96,1568.96) 1178.28 (743.32,1566.66) 17.15 178.20 (117.52,276.17) 143.02 (89.74,189) -19.74 Female 763.83 (493.38,1042.82) 875.14 (649.70,1156.06) 14.57 144.01 (93.80,195.96) 109.48 (80.78,144.78) -23.98 Both 1769.66 (1286.81,2432.38) 2053.42 (1584.34,2524.97) 16.03 161.29 (118.00,220.25) 126.24 (96.01,154.80) -21.73 Prostate cancer Male 403.11 (306.18,488.11) 1002.59 (794.01,1322.63) 148.71 125.93 (99.53,151.84) 118.94 (95.05,154.14) -5.55 Ovarian cancer Female 275.06 (212.26,377.97) 835.06 (612.56,1063.25) 203.59 55.57 (42.86,77.80) 80.52 (59.44,102.57) 44.90 Non-Hodgkin lymphoma Male 379.06 (316.14,449.30) 878.86 (702.20,1085.95) 131.85 70.67 (59.36,83.47) 95.58 (77.16,116.59) 35.25 Female 271.02 (228.59,317.56) 427.38 (345.89,521.43) 57.69 52.27 (44.2,61.23) 46.95 (38.28,56.63) -10.18 Both 650.08 (572.42,734.67) 1306.25 (1103.33,1521.35) 100.94 61.41 (54.34,69.17) 71.00 (60.64,81.81) 15.62 Nasopharynx cancer Male 624.47 (514.94,742.33) 692.83 (547.16,856.24) 10.95 120.19 (99.50,142.34) 69.51 (55.30,85.49) -42.17 Female 311.06 (248.27,375.31) 219.28 (172.23,273.09) -29.51 62.44 (49.82,75.26) 21.97 (17.34,27.27) -64.81 Both 935.53 (799.02,1072.20) 912.11 (760.83,1081.93) -2.50 91.67 (78.49,104.64) 45.60 (38.3,53.80) -50.26 Bladder cancer Male 280.05 (232.44,326.32) 651.10 (528.55,791.98) 132.49 76.38 (64.43,87.29) 73.49 (60.47,88.56) -3.78 Female 125.51 (103.00,150.03) 165.02 (132.47,202.22) 31.48 28.99 (23.89,34.61) 16.22 (13.05,19.85) -44.05 Both 405.56 (353.23,459.12) 816.12 (691.35,967.38) 101.23 49.41 (43.22,55.60) 41.88 (35.59,49.34) -15.24 Gallbladder and biliary tract cancer Male 146.74 (115.52,241.03) 410.61 (293.21,522.30) 179.82 34.26 (27.38,56.37) 42.60 (30.64,53.79) 24.34 Female 162.28 (123.28,279.48) 352.97 (220.46,453.95) 117.51 36.46 (27.95,62.67) 33.57 (20.96,43.23) -7.93 Both 309.02 (254.14,486.15) 763.58 (566.76,920.49) 147.10 35.18 (29.16,56.02) 37.71 (27.91,45.35) 7.19 Uterine cancer Female 332.05 (238.02,411.58) 364.28 (286.56,503.57) 9.71 69.61 (50.73,85.85) 34.93 (27.27,47.77) -49.82 Kidney cancer Male 121.56 (100.81,146.97) 462.87 (363.08,571.56) 280.77 24.44 (20.39,29.50) 49.65 (39.57,60.57) 103.15 Female 94.21 (81.14,107.59) 179.93 (147.91,216.68) 90.99 19.04 (16.49,21.63) 20.07 (16.75,23.75) 5.41 Both 215.76 (190.36,243.56) 642.8 (533.66,763.98) 197.92 21.59 (19.04,24.40) 34.28 (28.95,40.16) 58.78 Lip and oral cavity cancer Male 138.59 (112.35,166.48) 454.78 (360.26,571.48) 228.15 29.96 (24.49,35.71) 45.75 (36.55,56.94) 52.70 Female 84.05 (69.03,99.39) 121.02 (97.7,147.27) 43.99 17.75 (14.66,21.05) 11.94 (9.65,14.51) -32.73 Both 222.65 (192.53,252.40) 575.81 (479.52,690.74) 158.62 23.63 (20.48,26.66) 28.27 (23.59,33.71) 19.64 Larynx cancer Male 249.57 (201.04,296.26) 421.57 (337.84,519.58) 68.92 55.71 (45.4,65.32) 41.54 (33.47,51.01) -25.44 Female 68.15 (56.64,79.70) 76.36 (61.43,92.81) 12.05 14.87 (12.41,17.29) 7.34 (5.92,8.90) -50.64 Both 317.72 (268.27,367.83) 497.93 (411.84,600.18) 56.72 34.78 (29.53,40.08) 23.85 (19.81,28.62) -31.43 Multiple myeloma Male 75.98 (57.16,114.32) 203.66 (130.78,268.80) 168.04 16.32 (12.36,24.48) 20.57 (13.12,26.99) 26.04 Female 72.50 (54.07,109.05) 143.79 (99.65,187.87) 98.33 15.77 (11.8,23.42) 13.79 (9.45,17.82) -12.56 Both 148.48 (120.36,211.47) 347.45 (253.91,424.33) 134.00 16.03 (13.02,22.62) 17.05 (12.31,20.77) 6.36 Non-melanoma skin cancer Male 69.06 (56.89,81.03) 169.95 (136.49,208.25) 146.09 16.78 (13.93,19.51) 18.90 (15.39,22.89) 12.63 Female 59.94 (48.96,72.39) 154.42 (116.41,191.68) 157.62 13.21 (10.81,15.87) 15.23 (11.52,18.82) 15.29 Both 128.99 (112.67,146.36) 324.38 (272.52,376.46) 151.48 14.60 (12.82,16.49) 16.76 (14.18,19.38) 14.79 Thyroid cancer Male 38.44 (31.36,46.79) 107.11 (81.45,133.26) 178.64 8.36 (6.89,10.21) 11.64 (8.91,14.29) 39.23 Female 65.05 (52.36,80.81) 80.21 (64.74,99.49) 23.31 13.48 (10.98,16.66) 8.11 (6.55,10.07) -39.84 Both 103.49 (87.96,124.72) 187.32 (156.24,219.11) 81.00 10.87 (9.33,13.21) 9.7 (8.11,11.27) -10.76 Malignant skin melanoma Male 53.37 (32.04,74.11) 79.89 (45.35,108.93) 49.69 10.25 (6.22,14.22) 8.57 (4.96,11.69) -16.39 Female 42.42 (25,70.61) 70.23 (37.33,96.33) 65.56 8.62 (5.18,14.29) 7.32 (3.94,9.99) -15.08 Both 95.79 (63.30,137.80) 150.12 (93.91,189.54) 56.72 9.48 (6.41,13.87) 7.96 (5.06,9.99) -16.03 Other pharynx cancer Male 68.13 (55.59,81.27) 121.75 (92.99,152.68) 78.70 14.66 (12.10,17.33) 11.83 (9.13,14.79) -19.30 Female 20.48 (16.67,24.36) 23.73 (18.84,29.23) 15.87 4.38 (3.59,5.21) 2.30 (1.82,2.82) -47.49 Both 88.61 (75.24,102.57) 145.47 (117.12,176.32) 64.17 9.42 (8.06,10.85) 6.95 (5.61,8.40) -26.22 Testicular cancer Male 39.45 (33.11,45.47) 51.15 (42.02,61.19) 29.66 6.43 (5.42,7.41) 6.70 (5.52,7.90) 4.20 Hodgkin lymphoma Male 127.11 (60.21,167.15) 56.81 (39.45,75.09) -55.31 22.73 (10.79,29.93) 6.50 (4.61,8.58) -71.40 Female 77.23 (31.88,110.31) 29.36 (20.85,38.34) -61.98 14.31 (5.91,20.26) 3.44 (2.49,4.52) -75.96 Both 204.34 (103.13,269.11) 86.17 (65.53,105.33) -57.83 18.56 (9.44,24.32) 4.95 (3.85,6.08) -73.33 Mesothelioma Male 17.53 (13.46,25.13) 50.64 (39.12,65.81) 188.88 3.49 (2.71,5.05) 5.09 (3.94,6.55) 45.85 Female 18.79 (11.73,30.96) 28.48 (18.31,37.08) 51.57 3.87 (2.49,6.34) 2.81 (1.81,3.66) -27.39 Both 36.32 (27.23,51.58) 79.12 (65.07,94.57) 117.84 3.68 (2.80,5.23) 3.94 (3.24,4.7) 7.07
